Avantor® and bluewhale bio partner to accelerate car-t manufacturing with breakthrough cell activation and expansion technology

Radnor, pa. and philadelphia, oct. 15, 2025 /prnewswire/ -- avantor, inc. (nyse: avtr), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with bluewhale bio, a commercial-stage company dedicated to transforming immune cell therapy manufacturing and addressing the unmet need in car-t production by streamlining manufacturing, reducing variability, and shortening time-to-patient.
AVTR Ratings Summary
AVTR Quant Ranking